Durbin is dedicated to improving patient access to unlicensed medicine worldwide. Committed to quality and integrity, Durbin delivers its services with a ‘can-do’ attitude. Durbin serves healthcare practitioners and patients globally, including underserved markets in LATAM, APAC, CIS/EEU, Africa, and the Middle East. We go above and beyond to compliantly deliver unlicensed medicines to patients on time.
Durbin is part of the Uniphar Group. Uniphar is expressly focussed on the specialist treatments and orphan drug markets on a global level. The wide span of capabilities ensures that almost any requirement by a pharma company can be fulfilled.
www.durbin-eap.com
